微/纳米运动的最新进展,用于治疗和诊断动脉样硬化症
Yu-Sheng Qin1, Juan Yi2, Yan-Jun Chen3
1Department of Laboratory Medicine, Liuzhou Key Laboratory of Precision Medicine for Viral Diseases, Guangxi Health Commission Key Laboratory of Clinical Biotechnology (Liuzhou People's Hospital), Liuzhou People's Hospital, Liuzhou 545006, China.
ACS applied materials & interfaces
|December 9, 2024
概括
微/纳米电机通过导航循环系统并将药物直接输送到斑块上,提供有针对性的动脉样硬化治疗. 这种创新方法有望改善心血管疾病的治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 心血管研究研究心血管研究
背景情况:
- 动脉样性心血管疾病是全球主要的健康问题,死亡率和残疾率很高.
- 传统的动脉样硬化治疗缺乏向效果,可能会损害其他器官.
- 微/纳米发动机为心血管疾病的向输送和治疗提供了一个新的解决方案.
研究的目的:
- 审查用于治疗动脉样硬化心血管疾病的微/纳米运动技术的最新进展.
- 突出微/纳米电机在斑块定位,治疗和成像方面的潜力.
- 讨论微/纳米电机应用在这个领域的挑战和未来前景.
主要方法:
- 关于动脉样硬化中微/纳米运动应用的最新科学文献的综述.
- 分析超越循环系统内的生物障碍的微/纳米运动能力.
- 探索针对动脉样硬化斑块和细胞内传递的微/纳米运动策略.
主要成果:
- 微/纳米发动机在循环系统中显示出更强的透和保留能力.
- 这些设备有效地准动脉样硬化斑块的微环境,并促进细胞内药物输送.
- 微/纳米电机显示出可用于成像脆弱斑块的潜力.
结论:
- 微/纳米运动技术为动脉样硬化心血管疾病治疗提供了一个有希望的,有针对性的方法.
- 考虑疾病原因和微观环境的个性化管理策略至关重要.
- 需要进一步的研究和开发来克服挑战,并充分发挥微/纳米电机的潜力.
更多相关视频
相关概念视频
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
961
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747


